IMC · ASX

Immuron Limited (ASX:IMC)

AU$0.089

 -0.002 (-2.198%)
ASX:Live
10/10/2025 03:49:55 PM
HALO Price Momentum HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IMC Overview

IMC Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About IMC

Website

N/A

Telephone

61.3.8892.4802

Address

Unit 10 25-37 Chapman Street Blackburn, Victoria (VIC) 3131

Description

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. The Hyper-immune Products segment includes income and expenses directly attributable to Travelan and Protectyn activities. The Research and Development segment refers to the group’s R&D projects performed in Australia and United States. The company was founded on January 13, 1994, and is headquartered in Blackburn, Australia.

IMC Price Chart

Key Stats

Market Cap

AU$24.41M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.1

Trade Value (12mth)

AU$3,028.00

1 week

-1.09%

1 month

31.88%

YTD

16.67%

1 year

9.64%

All time high

15.60

Key Fundamentals

EPS 3 yr Growth

81.60%

EBITDA Margin

0.00%

Operating Cashflow

-$6m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

4.20

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

28-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IMC Announcements

Latest Announcements

Date Announcements

10 October 25

Notice of Annual General Meeting and Proxy Form

×

Notice of Annual General Meeting and Proxy Form

08 October 25

Immuron Submits IMM-529 IND to FDA

×

Immuron Submits IMM-529 IND to FDA

06 October 25

Immuron lodged ATM Prospectus Supplement with U.S. SEC

×

Immuron lodged ATM Prospectus Supplement with U.S. SEC

02 October 25

Letter to Shareholders

×

Letter to Shareholders

25 September 25

Annual Report

×

Annual Report

25 September 25

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

16 September 25

CEO's presentation to Coffee Microcaps Conference

×

CEO's presentation to Coffee Microcaps Conference

29 August 25

Appendix 4E Preliminary Final Report

×

Appendix 4E Preliminary Final Report

29 August 25

FY25 Results Presentation

×

FY25 Results Presentation

26 August 25

Immuron partners with InvestorHub

×

Immuron partners with InvestorHub

15 August 25

Notification regarding unquoted securities - IMC

×

Notification regarding unquoted securities - IMC

13 August 25

Emerging Growth Conference Presentation

×

Emerging Growth Conference Presentation

25 July 25

Presentation to Coffee Microcaps Conference

×

Presentation to Coffee Microcaps Conference

23 July 25

Change in substantial holding

×

Change in substantial holding

22 July 25

Notification of cessation of securities - IMC

×

Notification of cessation of securities - IMC

21 July 25

Application for quotation of securities - IMC

×

Application for quotation of securities - IMC

21 July 25

Notice under section 708A

×

Notice under section 708A

18 July 25

Application for quotation of securities - IMC

×

Application for quotation of securities - IMC

18 July 25

Notice under section 708A

×

Notice under section 708A

18 July 25

Proposed issue of securities - IMC

×

Proposed issue of securities - IMC

17 July 25

FY25 global sales exceed projection, up 49% on prior year

×

FY25 global sales exceed projection, up 49% on prior year

17 July 25

Application for quotation of securities - IMC

×

Application for quotation of securities - IMC

17 July 25

Notice under section 708A

×

Notice under section 708A

17 July 25

Proposed issue of securities - IMC

×

Proposed issue of securities - IMC

16 July 25

Proposed issue of securities - IMC

×

Proposed issue of securities - IMC

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IMC Shortsell

Frequently Asked Questions

The current share price of Immuron Limited (IMC:ASX) is AU$0.089.
The 52-week high share price for Immuron Limited (IMC:ASX) is AU$0.10.
The 52-week low share price for Immuron Limited (IMC:ASX)? is AU$0.05.
Immuron Limited (IMC:ASX) does not pay a dividend.
Immuron Limited (IMC:ASX) does not pay a dividend.
Immuron Limited (IMC:ASX) has a franking level of 0.0%.
Immuron Limited (IMC:ASX) is classified in the Healthcare.
The current P/E ratio for Immuron Limited (IMC:ASX) is .
The current share price of Immuron Limited (IMC:ASX) is AU$0.089.
The 52-week high share price for Immuron Limited (IMC:ASX) is AU$0.10.
The 52-week low share price for Immuron Limited (IMC:ASX)? is AU$0.05.
Immuron Limited (IMC:ASX) does not pay a dividend.
Immuron Limited (IMC:ASX) does not pay a dividend.
Immuron Limited (IMC:ASX) has a franking level of 0.0%.
Immuron Limited (IMC:ASX) is classified in the Healthcare.
The current P/E ratio for Immuron Limited (IMC:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox
App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.

Ff